AIM
RGNX icon

Aigen Investment Management’s Regenxbio RGNX Stock Holding History

Aigen Investment Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,998
Closed -$408K – 842
2020
Q4 		$408K Sell
8,998
-36,804
-80% -$1.29M 0.05% 445
2020
Q3 		$1.26M Buy
45,802
+36,863
+412% +$1.2M 0.16% 203
2020
Q2 		$329K Buy
+8,939
New +$333K 0.04% 594

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Aigen Investment Management's RGNX Position: Q1 2021 in Review

Aigen Investment Management sold out of Regenxbio (RGNX) in Q1 2021, closing a stake of 8,998 shares — an estimated $408K sold.

Aigen Investment Management first reported a position in RGNX in Q2 2020 and held it in 3 quarters. The position peaked at $1.26M in Q3 2020. 184 funds tracked by Wall St. Rank hold RGNX as of Q1 2021.

  • Aigen Investment Management reported no remaining Regenxbio position as of Q1 2021 after selling out during the quarter.
  • Aigen Investment Management sold 8,998 Regenxbio shares in Q1 2021, an estimated $408K.
  • Aigen Investment Management first reported a position in Regenxbio in Q2 2020 and held it in 3 quarters.
  • Aigen Investment Management's Regenxbio position peaked at $1.26M in Q3 2020.
  • 184 funds tracked by Wall St. Rank held Regenxbio as of Q1 2021.

Based on Aigen Investment Management's 13F filing for Q1 2021, filed 11 May 2021.